Micronesia, Federated States of vs Solomon Islands: Share of adolescent girls vaccinated against human papillomavirus
Micronesia, Federated States of
48.0%
in 2024
Solomon Islands
51.0%
in 2024
Micronesia, Federated States of rank
57th
Solomon Islands rank
56th
Share of adolescent girls vaccinated against human papillomavirus over time
- Micronesia, Federated States of
- Solomon Islands
How they compare
Solomon Islands currently reports 51.0% against 48.0% in Micronesia, Federated States of, a difference of 3.0%.
That makes Solomon Islands's figure about 1.1 times Micronesia, Federated States of's.
The two have swapped places 1 time across 5 shared years of data; in 2020 it was Micronesia, Federated States of ahead.
Micronesia, Federated States of ranks 57th and Solomon Islands ranks 56th of 74 countries.
Micronesia, Federated States of has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, Micronesia, Federated States of or Solomon Islands?
- Solomon Islands, at 51.0% against 48.0% in Micronesia, Federated States of as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between Micronesia, Federated States of and Solomon Islands?
- 3.0%, with Solomon Islands ahead.
- How many years of comparable data are there for Micronesia, Federated States of and Solomon Islands?
- 5 years are reported by both, from 2020 to 2024.
- How do Micronesia, Federated States of and Solomon Islands rank globally for share of adolescent girls vaccinated against human papillomavirus?
- Micronesia, Federated States of ranks 57th and Solomon Islands ranks 56th of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.